Auf dieser Seite
QURE uniQure N.V. - Ordinary Shares
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 29, 2026
$23,46
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$8,7352-Wochen-Tief
$71,5052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.63B
P/E (TTM)
-5.8
EPS (TTM)
$-4.02
Umsatz (TTM)
$19M
Ihre Abzeichen
52W-Spanne
$9–$72
Analystenbewertung
BUY
Kursziel
$65
P/E
-5.8
ROE
-157.6%
Nettogewinnmarge
-1350.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
QURE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$23.46
Marktkapitalisierung (MRQ)
$1.63B
P/E (TTM)
-5.8
EPS (TTM)
$-4.02
Umsatz (TTM)
$19M
ROE (TTM)
-157.6%
Verschuldungsgrad (MRQ)
0.2
52W-Spanne
$9–$72
QURE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$16M2016-12-31 → 2025-12-31
EPS$-3.462019-12-31 → 2025-12-31
Freier Cashflow$-178M2016-12-31 → 2025-12-31
Nettogewinnmarge-1350.7%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | QURE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -5.85-Jahres-Durchschnitt ≈-3.4 | ≈-3.4 | · | · | |
| P/S (TTM) | 87.15-Jahres-Durchschnitt ≈31.4 | ≈31.4 | · | · | |
| K/B (MRQ) | 5.05-Jahres-Durchschnitt ≈-23.0 | ≈-23.0 | · | · | |
| EV / EBITDA | -7.85-Jahres-Durchschnitt ≈-3.5 | ≈-3.5 | · | · | |
| Kurs / FCF (TTM) | -10.15-Jahres-Durchschnitt ≈-3.6 | ≈-3.6 | · | · | |
| Kurs / Cashflow (TTM) | -10.15-Jahres-Durchschnitt ≈-3.9 | ≈-3.9 | · | · | |
| EV / Revenue (EV / Umsatz) | 90.05-Jahres-Durchschnitt ≈28.0 | ≈28.0 | · | · | |
| EV / FCF | -8.15-Jahres-Durchschnitt ≈-3.5 | ≈-3.5 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 6.25-Jahres-Durchschnitt ≈5.5 | ≈5.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | QURE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -1071.5%5-Jahres-Durchschnitt ≈-738.3% | ≈-738.3% | · | · | |
| EBITDA Margin (EBITDA-Marge) | -1151.4%5-Jahres-Durchschnitt ≈-738.3% | ≈-738.3% | · | · | |
| Vorgewinnmarge (TTM) | -1313.0%5-Jahres-Durchschnitt ≈-813.5% | ≈-813.5% | · | · | |
| Nettogewinnmarge (TTM) | -1350.7%5-Jahres-Durchschnitt ≈-824.5% | ≈-824.5% | · | · | |
| ROA (TTM) | -32.1%5-Jahres-Durchschnitt ≈-12.6% | ≈-12.6% | · | · | |
| ROE (TTM) | -157.6%5-Jahres-Durchschnitt ≈-256.6% | ≈-256.6% | · | · | |
| ROIC | -76.7%5-Jahres-Durchschnitt ≈-113.3% | ≈-113.3% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | QURE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.25-Jahres-Durchschnitt ≈-1.3 | ≈-1.3 | · | · | |
| Liquiditätsgrad (MRQ) | 10.05-Jahres-Durchschnitt ≈10.5 | ≈10.5 | · | · | |
| Quick Ratio | 1.35-Jahres-Durchschnitt ≈5.3 | ≈5.3 | · | · | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.25-Jahres-Durchschnitt ≈-1.3 | ≈-1.3 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | QURE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -40.6%5-Jahres-Durchschnitt ≈232.5% | ≈232.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -46.7%5-Jahres-Durchschnitt ≈-44.8% | ≈-44.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -15.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | QURE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.2 | ≈0.2 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$72.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.1%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | $-1.22 | $-0.84 | -45.1% | |
| 31. März 2026 | Mai 12, 2026 | $-0.85 | $-0.89 | 4.9% |
| 31. Dezember 2025 | $-0.64 | $-0.97 | 33.7% | |
| 30. September 2025 | $-1.38 | $-0.92 | -50.4% | |
| 30. Juni 2025 | $-0.69 | $-0.91 | 24.4% | |
| 31. März 2025 | $-0.82 | $-1.03 | 20.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $27M | $16M | $106M | $524M | $38M | $7M | $11M | $13M | $25M | $11M | |
| Cost of Revenue | $2M | $1M | $65.0K | $1M | $25M | $3M | $2M | $1M | $817.0K | $1M | · | |
| R&D Expense | $141M | $144M | $215M | $198M | $144M | $122M | $95M | $75M | $72M | $73M | $59M | |
| SG&A Expense | $65M | $53M | $75M | $55M | $56M | $43M | $34M | $25M | $25M | $26M | $23M | |
| Operating Expenses | $208M | $215M | $303M | $256M | $225M | $165M | $128M | $100M | $97M | $99M | $83M | |
| Operating Income | $-185M | $-184M | $-283M | $-143M | $311M | $-125M | $-121M | $-88M | $-71M | $-72M | $-71M | |
| Interest Expense | · | · | $42M | $12M | $7M | $4M | $4M | $2M | $2M | $2M | $3M | |
| Interest Income | $17M | $21M | $20M | $609.0K | $162.0K | $938.0K | $4M | $3M | $117.0K | $70.0K | $121.0K | |
| Other Non-op | $11M | · | · | $3M | $-160.0K | $483.0K | $-3M | $208.0K | $-2M | $785.0K | $-7M | |
| Pretax Income | $-193M | $-237M | $-307M | $-128M | $333M | $-141M | $-124M | $-83M | $-79M | $-72M | $-83M | |
| Income Tax | $6M | $2M | $2M | $-1M | $3M | $-16M | · | $231.0K | $-199.0K | $1M | $-1M | |
| Net Income | $-199M | $-240M | $-308M | $-127M | $330M | $-125M | $-124M | $-83M | $-79M | $-73M | $-82M | |
| EPS (Basic) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.17 | $-2.81 | $-3.11 | · | · | · | · | |
| EPS (Diluted) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 | $-2.81 | $-3.11 | · | · | · | · | |
| Shares (Basic) | 57,502,068 | 48,649,129 | 47,670,986 | 46,735,045 | 45,986,467 | 44,466,365 | 39,999,450 | · | · | · | · | |
| Shares (Diluted) | 57,502,068 | 48,649,129 | 47,670,986 | 46,735,045 | 46,840,972 | 44,466,365 | 39,999,450 | · | · | · | · | |
| EBITDA | $-185M | $-184M | $-283M | $-143M | $311M | $-125M | $-121M | · | $-71M | $-72M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $80M | $159M | $241M | $228M | $556M | $245M | $378M | $235M | $159M | $132M | $222M | |
| Receivables | $6M | · | · | · | · | $7M | · | · | · | $4M | · | |
| Inventory | · | · | $12M | $7M | · | · | · | · | · | · | $474.0K | |
| Prepaid Expense | $21M | $9M | $15M | $12M | $11M | $4M | $5M | $1M | $1M | $996.0K | $690.0K | |
| Other Current Assets | · | · | · | · | · | $3M | $748.0K | $329.0K | $687.0K | $1M | $1M | |
| Current Assets | $656M | $390M | $652M | $477M | $628M | $259M | $384M | $237M | $163M | $144M | $228M | |
| PP&E (Net) | $14M | $20M | $47M | $51M | $44M | $32M | $29M | $29M | $34M | $36M | $26M | |
| PP&E (Gross) | $58M | $52M | $102M | $95M | $80M | $68M | $57M | $52M | $51M | $48M | $37M | |
| Accum. Depreciation | $44M | $32M | $56M | $44M | $37M | $35M | $29M | $23M | $17M | $12M | $11M | |
| Goodwill | $25M | $22M | $26M | $26M | $28M | $542.0K | $496.0K | $506.0K | $530.0K | $465.0K | $481.0K | |
| Intangibles | $73M | $71M | $60M | $59M | $63M | $3M | $5M | $5M | $10M | $8M | $7M | |
| Other Non-current Assets | $6M | $1M | $3M | $6M | $6M | $3M | · | · | $2M | $2M | $1M | |
| Total Assets | $825M | $557M | $832M | $705M | $809M | $340M | $449M | $274M | $210M | $190M | $263M | |
| Accounts Payable | $5M | $7M | $7M | $11M | $3M | $4M | $6M | $4M | $3M | $6M | $4M | |
| Accrued Liabilities | $41M | $29M | $31M | $31M | $28M | $18M | $12M | $8M | · | · | · | |
| Current Liabilities | $63M | $40M | $74M | $76M | $37M | $27M | $32M | $20M | $19M | $23M | $27M | |
| Capital Leases | $10M | $11M | $28M | $32M | $29M | $30M | $31M | · | · | · | · | |
| Deferred Tax | $8M | $7M | $8M | $8M | $13M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $4M | $8M | $4M | $935.0K | $4M | $3M | $534.0K | $435.0K | $614.0K | $51.0K | $578.0K | |
| Total Liabilities | $626M | $563M | $624M | $229M | $213M | $96M | $126M | $94M | $120M | $127M | $135M | |
| Long-term Debt | $72M | $66M | $148M | $144M | $136M | $42M | $47M | $48M | $24M | $20M | $20M | |
| Total Debt | $50M | $51M | $102M | $103M | $101M | $36M | $36M | · | $21M | $20M | · | |
| Common Stock | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $1.58B | $1.17B | $1.15B | $1.11B | $1.08B | $1.02B | $987M | $720M | $567M | $465M | $456M | |
| Retained Earnings | $-1.33B | $-1.13B | $-890M | $-582M | $-455M | $-785M | $-660M | $-536M | $-475M | $-396M | $-323M | |
| AOCI | $-58M | $-53M | $-54M | $-58M | $-29M | $-10M | $-7M | $-7M | $-4M | $-7M | $-7M | |
| Stockholders' Equity | $199M | $-7M | $208M | $476M | $596M | $244M | $323M | $180M | $89M | $64M | $128M | |
| Liabilities + Equity | $825M | $557M | $832M | $705M | $809M | $340M | $449M | $274M | $210M | $190M | $263M | |
| Shares Outstanding | 62,336,717 | 48,988,087 | 47,833,830 | 46,968,032 | 46,298,635 | 44,777,799 | 43,711,954 | 37,351,653 | 31,339,040 | 25,257,420 | 24,327,944 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $13M | $12M | $9M | $7M | $11M | $7M | $12M | $8M | · | · | |
| Stock-based Comp | $18M | $22M | $35M | $34M | $26M | $22M | $18M | $11M | $10M | $6M | $12M | |
| Deferred Tax | $2M | $2M | $2M | $-1M | $3M | $-16M | · | $209.0K | $-209.0K | $1M | $-1M | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-178M | $-183M | $-146M | $-145M | $288M | $-135M | $-99M | $-76M | $-64M | $-72M | $7M | |
| CapEx | $439.0K | $3M | $7M | $18M | $17M | $7M | $6M | $2M | $4M | $15M | $8M | |
| Investing Cash Flow | $-322M | $163M | $-206M | $-183M | $-67M | $-9M | $-7M | $-4M | $-6M | $-17M | $-8M | |
| Debt Issued | · | · | · | · | $64M | · | · | $15M | · | · | · | |
| Net Debt Issued | · | $-53M | · | · | $64M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $31M | $7M | $6M | $5M | $4M | $3M | $3M | |
| Net Stock Activity | · | · | · | · | $3M | $7M | $6M | · | $4M | $3M | · | |
| Financing Cash Flow | $415M | $-59M | $363M | $1M | $95M | $7M | $249M | $158M | $90M | $2M | $161M | |
| Net Change in Cash | $-79M | $-84M | $13M | $-328M | $312M | $-133M | $143M | $75M | $28M | $-89M | $157M | |
| Taxes Paid | $8M | $21.0K | $12.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-178M | $-186M | $-153M | $-163M | $271M | $-142M | $-104M | · | $-69M | $-87M | · | |
| Levered FCF | · | · | $-195M | $-174M | $263M | $-145M | · | · | $-71M | $-90M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% | -334.3% | -1663.8% | · | -544.3% | -286.7% | · | |
| Net Margin | -1236.0% | -883.4% | -1947.1% | -119.1% | 62.9% | -333.3% | -1705.8% | · | -604.7% | · | · | |
| Pretax Margin | -1201.0% | -874.4% | -1935.0% | -120.4% | 63.5% | -377.0% | -1705.8% | · | -606.2% | -287.8% | · | |
| EBITDA Margin | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% | -334.3% | -1663.8% | · | -544.3% | -286.7% | · | |
| ROA | -28.8% | -34.5% | -40.2% | -16.8% | 57.3% | -31.7% | -34.4% | · | -39.6% | · | · | |
| ROE | -204.2% | -976.4% | -129.5% | -28.3% | 55.6% | -53.0% | -36.9% | · | -103.6% | · | · | |
| ROIC | -76.7% | -417.7% | -92.0% | -24.4% | 44.1% | -39.7% | · | · | -64.6% | -87.2% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.4 | 9.7 | 8.8 | 6.3 | 17.1 | 9.5 | 12.1 | · | 8.5 | 6.3 | · | |
| Quick Ratio | 1.3 | 4.0 | 3.3 | 3.0 | 15.1 | 9.2 | 11.9 | · | 8.3 | 6.0 | · | |
| Debt / Equity | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | · | |
| LT Debt / Equity | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | · | |
| Interest Coverage | · | · | -6.8 | -12.2 | 41.6 | -32.8 | -31.8 | · | -32.0 | -33.1 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | 0.9 | 0.1 | 0.0 | · | 0.1 | 0.1 | · | |
| Inventory Turnover | · | · | 0.0 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 7.3 | · | · | · | 13.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.19 | $-0.14 | $4.34 | $10.13 | $12.87 | $5.45 | $7.39 | · | $2.85 | $2.52 | · | |
| Revenue / Share | $0.28 | $0.56 | $0.33 | $2.28 | $11.19 | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.09 | $-3.76 | $-3.06 | $-3.10 | $6.15 | · | · | · | · | · | · | |
| Cash / Share | $1.29 | $3.24 | $5.05 | $4.85 | $12.01 | $5.47 | $8.64 | · | $5.09 | $5.25 | · | |
| EPS (TTM) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 | $-2.81 | $-3.11 | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -40.6% | 71.2% | -85.1% | -79.7% | 1296.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -46.7% | -62.7% | -25.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -15.6% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16M | $27M | $16M | $106M | $524M | $38M | $7M | $11M | $13M | $25M | · | |
| Net Income TTM | $-199M | $-240M | $-308M | $-127M | $330M | $-125M | $-124M | $-83M | $-79M | $-73M | · | |
| Market Cap | $1.49B | $865M | $324M | $1.06B | $960M | $1.62B | $3.13B | · | $614M | $141M | · | |
| Enterprise Value | $1.46B | $758M | $184M | $940M | $505M | $1.41B | $2.79B | · | $475M | $29M | · | |
| P/E | -6.9 | -3.6 | -1.0 | -8.4 | 2.9 | -12.9 | -23.0 | · | · | · | · | |
| P/S | 92.7 | 31.9 | 20.4 | 10.0 | 1.8 | 43.1 | 430.2 | · | 46.8 | 5.6 | · | |
| P/B | 7.5 | -128.1 | 1.6 | 2.2 | 1.6 | 6.6 | 9.7 | · | 6.9 | 2.2 | · | |
| P / Tangible Book | 14.8 | · | 2.7 | 2.7 | 1.9 | 6.7 | · | · | · | · | · | |
| P / Cash Flow | -8.4 | -4.7 | -2.2 | -7.3 | 3.3 | -12.0 | -31.7 | · | -9.6 | -2.0 | · | |
| P / FCF | -8.4 | -4.6 | -2.1 | -6.5 | 3.5 | -11.4 | -30.0 | · | -8.9 | -1.6 | · | |
| EV / EBITDA | -7.9 | -4.1 | -0.7 | -6.6 | 1.6 | -11.2 | -23.0 | · | -6.7 | -0.4 | · | |
| EV / FCF | -8.2 | -4.1 | -1.2 | -5.8 | 1.9 | -9.9 | -26.7 | · | -6.9 | -0.3 | · | |
| EV / Revenue | 90.8 | 27.9 | 11.6 | 8.8 | 1.0 | 37.5 | 383.3 | · | 36.3 | 1.2 | · | |
| Earnings Yield | -14.5% | -27.9% | -95.6% | -11.9% | 33.9% | -7.8% | -4.3% | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $4M | $6M | $4M | $5M | $2M | $5M | $2M | $11M | $8M | $7M | $1M | $2M | $5M | $103M | $1M | |
| Cost of Revenue | $350.0K | $219.0K | $435.0K | $398.0K | $656.0K | $197.0K | $619.0K | $264.0K | $234.0K | $150.0K | · | · | · | · | · | · | |
| R&D Expense | $34M | $29M | $35M | $34M | $35M | $36M | $39M | $31M | $34M | $41M | $43M | $65M | $46M | $61M | $58M | $48M | |
| SG&A Expense | $17M | $20M | $22M | $19M | $14M | $11M | $11M | $12M | $16M | $14M | $17M | $18M | $21M | $18M | $18M | $13M | |
| Operating Expenses | $52M | $49M | $57M | $54M | $50M | $47M | $51M | $43M | $57M | $64M | $69M | $84M | $69M | $81M | $78M | $62M | |
| Operating Income | $-52M | $-46M | $-51M | $-51M | $-44M | $-39M | $-46M | $-40M | $-44M | $-54M | $-62M | $-82M | $-65M | $-74M | $26M | $-60M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $16M | · | $15M | $7M | $4M | · | $3M | |
| Interest Income | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $3M | $2M | $493.0K | $39.0K | |
| Other Non-op | $-16M | $4M | $18M | $-7M | · | · | · | · | · | · | · | · | · | · | $2M | $0 | |
| Pretax Income | $-79M | $-53M | $-41M | $-72M | $-37M | $-43M | $-72M | $-44M | $-55M | $-65M | $-70M | $-90M | $-68M | $-78M | $7M | $-48M | |
| Income Tax | $2M | $488.0K | $-4M | $9M | $425.0K | $496.0K | $856.0K | $-31.0K | $948.0K | $656.0K | $3M | $-69.0K | $163.0K | $-1M | $-207.0K | $-329.0K | |
| Net Income | $-81M | $-54M | $-37M | $-81M | $-38M | $-44M | $-73M | $-44M | $-56M | $-66M | $-73M | $-90M | $-68M | $-77M | $7M | $-48M | |
| EPS (Basic) | $-1.22 | $-0.85 | $-0.57 | $-1.38 | $-0.69 | $-0.82 | $-1.49 | $-0.91 | $-1.16 | $-1.36 | $-1.52 | $-1.88 | $-1.44 | $-1.63 | $0.15 | $-1.02 | |
| EPS (Diluted) | $-1.22 | $-0.85 | $-0.57 | $-1.38 | $-0.69 | $-0.82 | $-1.49 | $-0.91 | $-1.16 | $-1.36 | $-1.52 | $-1.88 | $-1.44 | $-1.63 | $0.15 | $-1.02 | |
| Shares (Basic) | 66,243,879 | 62,742,847 | · | 58,516,415 | 54,807,967 | 53,110,580 | · | 48,718,533 | 48,622,440 | 48,384,510 | · | 47,770,101 | 47,649,520 | 47,436,335 | · | 46,772,430 | |
| Shares (Diluted) | 66,243,879 | 62,742,847 | · | 58,516,415 | 54,807,967 | 53,110,580 | · | 48,718,533 | 48,622,440 | 48,384,510 | · | 47,770,101 | 47,649,520 | 47,436,335 | · | 46,772,430 | |
| EBITDA | $-52M | $-46M | · | $-51M | $-44M | $-39M | · | $-40M | $-44M | $-54M | · | $-82M | $-65M | $-74M | · | $-60M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $413M | $140M | $80M | $597M | $254M | $217M | $159M | $252M | $288M | $243M | $241M | $229M | $514M | $154M | $228M | $440M | |
| Receivables | $6M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | $8M | · | $16M | $10M | $7M | · | $4M | |
| Prepaid Expense | $10M | $17M | $21M | $10M | $19M | $13M | $9M | $19M | $18M | $19M | · | $15M | $12M | $13M | · | $14M | |
| Current Assets | $834M | $616M | $656M | $716M | $409M | $435M | $390M | $464M | $592M | $596M | · | $694M | $757M | $443M | · | $465M | |
| PP&E (Net) | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $26M | $26M | $45M | · | $46M | $49M | $50M | · | $48M | |
| PP&E (Gross) | · | · | $58M | · | · | · | $52M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $44M | $44M | $41M | $36M | $32M | $31M | $28M | $58M | · | $52M | $49M | $47M | · | $40M | |
| Goodwill | $25M | $25M | $25M | $25M | $25M | $23M | $22M | $24M | $23M | $26M | · | $25M | $26M | $26M | · | $23M | |
| Intangibles | $62M | $70M | $73M | $74M | $76M | $72M | $71M | $77M | $59M | $59M | · | $58M | $60M | $60M | · | $54M | |
| Other Non-current Assets | $5M | $6M | $6M | $5M | $5M | $5M | $1M | $1M | $5M | $5M | · | $6M | $6M | $6M | · | $6M | |
| Total Assets | $985M | $779M | $825M | $888M | $585M | $605M | $557M | $646M | $731M | $770M | · | $872M | $943M | $631M | · | $638M | |
| Accounts Payable | $5M | $4M | $5M | $6M | $6M | $5M | $7M | $5M | $4M | $5M | · | $6M | $9M | $9M | · | $8M | |
| Accrued Liabilities | $51M | $43M | $41M | $52M | $31M | $27M | $29M | $32M | $26M | $23M | · | $28M | $24M | $23M | · | $26M | |
| Current Liabilities | $83M | $59M | $63M | $101M | $41M | $36M | $40M | $71M | $80M | $63M | · | $69M | $68M | $66M | · | $64M | |
| Capital Leases | $10M | $10M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $27M | · | $29M | $30M | $31M | · | $30M | |
| Deferred Tax | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $7M | · | $5M | $7M | $7M | · | $9M | |
| Other Non-current Liabilities | $3M | $3M | $4M | $6M | $6M | $6M | $8M | $9M | $3M | $3M | · | $1M | $960.0K | $958.0K | · | $3M | |
| Total Liabilities | $661M | $629M | $626M | $660M | $589M | $572M | $563M | $590M | $634M | $623M | · | $603M | $589M | $218M | · | $217M | |
| Long-term Debt | · | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $50M | $50M | · | $52M | $52M | $52M | · | $51M | $103M | $102M | · | $101M | $101M | $103M | · | $102M | |
| Common Stock | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Paid-in Capital | $1.84B | $1.59B | $1.58B | $1.58B | $1.26B | $1.26B | $1.17B | $1.17B | $1.16B | $1.16B | · | $1.14B | $1.13B | $1.12B | · | $1.10B | |
| Retained Earnings | $-1.46B | $-1.38B | $-1.33B | $-1.29B | $-1.21B | $-1.17B | $-1.13B | $-1.06B | $-1.01B | $-956M | · | $-817M | $-728M | $-659M | · | $-589M | |
| AOCI | $-58M | $-60M | $-58M | $-59M | $-59M | $-54M | $-53M | $-57M | $-56M | $-56M | · | $-59M | $-52M | $-52M | $-58M | $-93M | |
| Stockholders' Equity | $324M | $149M | $199M | $229M | $-4M | $34M | $-7M | $56M | $97M | $147M | $208M | $269M | $353M | $413M | $476M | $421M | |
| Liabilities + Equity | $985M | $779M | $825M | $888M | $585M | $605M | $557M | $646M | $731M | $770M | · | $872M | $943M | $631M | · | $638M | |
| Shares Outstanding | 69,334,839 | 63,033,249 | 62,336,717 | 62,165,900 | 54,865,673 | 54,698,479 | 48,988,087 | 48,738,874 | 48,694,569 | 48,492,357 | 47,833,830 | 47,810,291 | 47,702,331 | 47,546,673 | 46,968,032 | 46,815,109 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $3M | $3M | $4M | $4M | $5M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | · | $2M | |
| Stock-based Comp | $5M | $5M | $5M | $4M | $5M | $4M | $5M | $3M | $7M | $7M | $7M | $11M | $9M | $8M | $12M | $8M | |
| Deferred Tax | $2M | $500.0K | $-391.0K | $1M | $400.0K | $500.0K | $871.0K | $-120.0K | · | · | $3M | $-69.0K | $163.0K | $-1M | $-231.0K | $-329.0K | |
| Operating Cash Flow | $-29M | $-38M | $-78M | $-16M | $-40M | $-44M | $-53M | $-37M | $-33M | $-61M | $-50M | $39M | $-57M | $-78M | $-55M | $-49M | |
| CapEx | $472.0K | $140.0K | $119.0K | $-66.0K | $260.0K | $126.0K | $40.0K | $380.0K | $604.0K | $2M | $2M | $2M | $1M | $2M | $5M | $4M | |
| Investing Cash Flow | $53M | $99M | $-441M | $27M | $73M | $20M | $-27M | $48M | $78M | $64M | $60M | $-314M | $46M | $3M | $-168M | $-5M | |
| Financing Cash Flow | $249M | $550.0K | $2M | $332M | $44.0K | $81M | $-7M | $-53M | · | · | $46.0K | $-8M | $370M | $131.0K | $601.0K | $301.0K | |
| Net Change in Cash | $273M | $60M | $-517M | $343M | $37M | $58M | $-93M | $-38M | $45M | $2M | $12M | $-284M | $360M | $-74M | $-212M | $-60M | |
| Free Cash Flow | · | $-38M | · | · | · | $-44M | · | · | · | $-63M | · | · | · | $-81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-79M | · | · | · | $-84M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -893.7% | -1283.5% | · | -1379.0% | -833.6% | -2510.0% | · | -1759.0% | -395.6% | -639.1% | · | -5819.3% | -2686.8% | -1392.9% | · | -4107.5% | |
| Net Margin | -1387.8% | -1503.0% | · | -2175.9% | -716.8% | -2784.8% | · | · | · | -773.3% | · | · | · | -1450.3% | · | · | |
| Pretax Margin | -1356.2% | -1489.2% | · | -1942.8% | -708.7% | -2753.1% | · | -1941.8% | -497.5% | -765.6% | · | -6371.0% | -2820.4% | -1472.9% | · | -3325.5% | |
| EBITDA Margin | -893.7% | -1283.5% | · | -1379.0% | -833.6% | -2510.0% | · | -1759.0% | -395.6% | -639.1% | · | -5819.3% | -2686.8% | -1392.9% | · | -4107.5% | |
| ROA | -10.3% | -7.7% | · | -10.5% | -5.7% | -6.3% | · | · | · | -9.4% | · | · | · | -11.1% | · | · | |
| ROE | -50.6% | -58.5% | · | -56.6% | -81.0% | -48.4% | · | · | · | -23.4% | · | · | · | -16.1% | · | · | |
| ROIC | -14.3% | -23.2% | · | -20.4% | -92.7% | -46.7% | · | -37.6% | -22.4% | -22.0% | · | -22.1% | -14.3% | -14.1% | · | -11.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.4 | · | 7.1 | 10.0 | 12.0 | · | 6.5 | 7.4 | 9.4 | · | 10.1 | 11.1 | 6.7 | · | 7.3 | |
| Quick Ratio | 5.0 | 2.4 | · | 5.9 | 6.2 | 6.0 | · | 3.5 | 3.6 | 3.8 | · | 3.3 | 7.5 | 2.3 | · | 6.9 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.2 | -13.0 | 1.5 | · | 0.9 | 1.1 | 0.7 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.2 | -13.0 | 1.5 | · | 0.9 | 1.1 | 0.7 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.4 | · | -5.3 | -9.5 | -20.8 | · | -19.4 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 0.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.67 | $2.37 | · | $3.68 | $-0.07 | $0.62 | · | $1.15 | $1.99 | $3.03 | · | $5.62 | $7.41 | $8.68 | · | $9.00 | |
| Revenue / Share | $0.09 | $0.06 | · | $0.06 | $0.10 | $0.03 | · | $0.05 | $0.23 | $0.18 | · | $0.03 | $0.05 | $0.11 | · | $0.03 | |
| Cash Flow / Share | · | $-0.61 | · | · | · | $-0.83 | · | · | · | $-1.25 | · | · | · | $-1.65 | · | · | |
| Cash / Share | $5.96 | $2.22 | · | $9.60 | $4.63 | $3.97 | · | $5.16 | $5.91 | $5.01 | · | $4.80 | $10.77 | $3.24 | · | $9.41 | |
| EPS (TTM) | $-4.02 | $-3.49 | · | $-4.38 | $-3.91 | $-4.38 | · | $-4.95 | $-5.92 | $-6.20 | · | $-4.80 | $-3.94 | $-3.34 | · | $-2.63 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $18M | · | $16M | $14M | $20M | · | $29M | $28M | $19M | · | $112M | $112M | $110M | · | $61M | |
| Net Income TTM | $-252M | $-209M | · | $-235M | $-199M | $-218M | · | $-240M | $-285M | $-297M | · | $-228M | $-187M | $-157M | · | $-125M | |
| Market Cap | $3.19B | $1.03B | · | $3.63B | $765M | $580M | · | $240M | $218M | $252M | · | $321M | $547M | $958M | · | $878M | |
| Enterprise Value | $2.83B | $941M | · | $3.08B | $563M | $414M | · | $40M | $33M | $111M | · | $193M | $134M | $907M | · | $540M | |
| P/E | -11.5 | -4.7 | · | -13.3 | -3.6 | -2.4 | · | -1.0 | -0.8 | -0.8 | · | -1.4 | -2.9 | -6.0 | · | -7.1 | |
| P/S | 171.0 | 57.0 | · | 230.4 | 53.3 | 28.7 | · | 8.4 | 7.9 | 13.3 | · | 2.9 | 4.9 | 8.7 | · | 14.3 | |
| P/B | 9.9 | 6.9 | · | 15.9 | -191.1 | 17.2 | · | 4.3 | 2.2 | 1.7 | · | 1.2 | 1.5 | 2.3 | · | 2.1 | |
| P / Tangible Book | 13.5 | 18.9 | · | 28.1 | · | · | · | · | 14.2 | 4.1 | · | 1.7 | 2.0 | 2.9 | · | 2.6 | |
| P / Cash Flow | · | -26.9 | · | · | · | -13.1 | · | · | · | -4.2 | · | · | · | -12.2 | · | · | |
| EV / Revenue | 151.6 | 52.0 | · | 195.8 | 39.3 | 20.5 | · | 1.4 | 1.2 | 5.9 | · | 1.7 | 1.2 | 8.2 | · | 8.8 | |
| Earnings Yield | -8.7% | -21.3% | · | -7.5% | -28.1% | -41.3% | · | -100.4% | -132.1% | -119.2% | · | -71.5% | -34.4% | -16.6% | · | -14.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $16M | $27M | $16M | $106M | $524M |
| Betriebsgewinnmarge % | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% |
| Nettoergebnis | $-199M | $-240M | $-308M | $-127M | $330M |
| Verwässerte EPS | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 |
| Liquiditätsgrad | 10.4 | 9.7 | 8.8 | 6.3 | 17.1 |
| Quick Ratio | 1.3 | 4.0 | 3.3 | 3.0 | 15.1 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-178M | $-186M | $-153M | $-163M | $271M |
Institutionelle Eigentümer (13F) 312 Einreicher · $3.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
312
Gehaltener Wert
$3.6B
Neue Positionen
98
Geschlossene Positionen
45
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 98 (+36 vs. Vorquartal) | 45 (-3 vs. Vorquartal) | 97 (+9 vs. Vorquartal) | 80 (+6 vs. Vorquartal) | +1.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $309.881.409 | 6.727.777 | 8,58% | Aktien |
| JPMORGAN CHASE & CO | $230.813.250 | 4.867.755 | 6,39% | Aktien |
| RTW INVESTMENTS, LP | $181.548.806 | 3.941.572 | 5,02% | Aktien |
| STATE STREET CORP | $133.750.180 | 2.903.825 | 3,70% | Aktien |
| Aberdeen Group plc | $131.184.269 | 2.848.117 | 3,63% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $118.728.862 | 2.577.700 | 3,29% | Kaufoption |
| BlackRock, Inc. | $86.475.484 | 1.877.453 | 2,39% | Aktien |
| ORBIMED ADVISORS LLC | $83.252.805 | 1.807.486 | 2,30% | Aktien |
| Caption Management, LLC | $74.967.256 | 1.627.600 | 2,07% | Kaufoption |
| JANE STREET GROUP, LLC | $74.178.847 | 1.610.483 | 2,05% | Aktien |
| JENNISON ASSOCIATES LLC | $71.918.636 | 1.561.412 | 1,99% | Aktien |
| Boxer Capital Management, LLC | $69.241.998 | 1.503.300 | 1,92% | Aktien |
| GOLDMAN SACHS GROUP INC | $67.982.533 | 1.475.956 | 1,88% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $67.340.825 | 1.462.024 | 1,86% | Aktien |
| Two Seas Capital LP | $66.391.345 | 1.441.410 | 1,84% | Aktien |
| FMR LLC | $58.499.338 | 1.270.068 | 1,62% | Aktien |
| MAK CAPITAL ONE LLC | $56.748.269 | 1.232.051 | 1,57% | Aktien |
| MPM BIOIMPACT LLC | $56.462.881 | 1.225.855 | 1,56% | Aktien |
| MORGAN STANLEY | $49.129.407 | 1.066.639 | 1,36% | Aktien |
| CITADEL ADVISORS LLC | $46.069.212 | 1.000.200 | 1,27% | Kaufoption |
| Vestal Point Capital, LP | $43.066.100 | 935.000 | 1,19% | Aktien |
| MAVERICK CAPITAL LTD | $42.623.141 | 925.383 | 1,18% | Aktien |
| CITADEL ADVISORS LLC | $41.930.168 | 910.338 | 1,16% | Aktien |
| Fiera Capital Corp | $41.875.034 | 909.141 | 1,16% | Aktien |
| Integral Health Asset Management, LLC | $41.454.000 | 900.000 | 1,15% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $39.658.136 | 860.631 | 1,10% | Aktien |
| Longaeva Partners L.P. | $37.059.600 | 804.594 | 1,03% | Aktien |
| Nantahala Capital Management, LLC | $36.848.000 | 800.000 | 1,02% | Kaufoption |
| VANGUARD CAPITAL MANAGEMENT LLC | $35.916.621 | 779.779 | 0,99% | Aktien |
| CITIGROUP INC | $30.629.900 | 665.000 | 0,85% | Kaufoption |
| Invesco Ltd. | $28.917.526 | 627.823 | 0,80% | Aktien |
| First Turn Management, LLC | $28.047.086 | 608.925 | 0,78% | Aktien |
| Point72 Asset Management, L.P. | $27.922.125 | 606.212 | 0,77% | Aktien |
| CITADEL ADVISORS LLC | $27.484.002 | 596.700 | 0,76% | Verkaufsoption |
| Balyasny Asset Management L.P. | $27.017.967 | 586.582 | 0,75% | Aktien |
| Kinetic Partners Management, LP | $26.760.860 | 581.000 | 0,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $26.658.884 | 578.786 | 0,74% | Aktien |
| TWO SIGMA ADVISERS, LP | $26.571.872 | 1.110.400 | 0,74% | Aktien |
| 683 Capital Management, LLC | $26.484.501 | 575.000 | 0,73% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $25.254.698 | 548.300 | 0,70% | Kaufoption |
| JANE STREET GROUP, LLC | $25.231.668 | 547.800 | 0,70% | Kaufoption |
| VANGUARD GROUP INC | $25.159.500 | 1.051.379 | 0,70% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $24.456.893 | 530.979 | 0,68% | Aktien |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $24.028.443 | 521.677 | 0,66% | Aktien |
| Assenagon Asset Management S.A. | $23.653.192 | 513.530 | 0,65% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.887.076 | 496.897 | 0,63% | Aktien |
| UBS Group AG | $21.536.321 | 467.571 | 0,60% | Aktien |
| Nantahala Capital Management, LLC | $20.987.700 | 455.660 | 0,58% | Aktien |
| Voss Capital, LP | $20.743.628 | 450.361 | 0,57% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.349.806 | 420.100 | 0,54% | Verkaufsoption |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Coller Investment Management Limited, Coller International General Partner V, L.P, Coller International Partners V-A, L.P ×4 Einreichungen | 3. April 2019 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 17 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Matthew C Kapusta | CEO, Managing Director | 2. Juli 2026 M | 519.227 | 0 | 16 | $-12.864.927 |
| Christian Klemt | Chief Financial Officer | 4. März 2026 A | 226.581 | 0 | 3 | $-381.751 |
| Ricardo Dolmetsch | President, R&D | 18. September 2023 S | 163.404 | 0 | 0 | $0 |
| Pierre Caloz | Chief Operating Officer | 17. Juni 2024 S | 115.707 | 0 | 0 | $0 |
| Scott T. Mcmillan | Chief Operating Officer | 28. Januar 2019 S | 20.432 | 0 | 0 | $0 |
| Walid Abi-Saab | Chief Medical Officer | 30. Juni 2026 M | 148.235 | 0 | 7 | $-2.611.134 |
| Jeannette Potts | Chief Legal Officer | 15. Juni 2026 S | 133.246 | 0 | 3 | $-261.172 |
| Kylie O'Keefe | Chief Customer & Strat Officer | 11. Juni 2026 S | 108.864 | 0 | 1 | $-431.228 |
| Alexander Edward Kuta III | Executive VP, Operations | 7. März 2023 S | 90.381 | 0 | 0 | $0 |
| Sander Van Deventer | EVP, Research & Product Dev. | 27. Februar 2020 A | 61.599 | 0 | 0 | $0 |
| Steven Zelenkofske | Chief Medical Officer | 6. Juni 2018 S | 159.458 | 0 | 0 | $0 |
| Jonathan Garen | Chief Business Officer | 26. Januar 2018 A | 93.638 | 0 | 0 | $0 |
| Paul E Firuta | Chief Commercial Officer | 26. Januar 2018 A | 93.817 | 0 | 0 | $0 |
| Maria E Cantor | SVP, Investor Rel. & Comm. | 26. Januar 2018 A | 92.439 | 0 | 0 | $0 |
| Harald Petry | Chief Scientific Officer | 29. Juni 2017 M | 0 | 0 | 0 | $0 |
| Christian Meyer | Chief Medical Officer | 27. Januar 2017 A | · | 0 | 0 | $0 |
| Maiken Keson-Brookes | General Counsel | 27. Januar 2017 A | · | 0 | 0 | $0 |
| Jack Kaye | Direktor | 30. Juni 2026 M | 25.996 | 0 | 9 | $-2.693.581 |
| Madhavan Balachandran | Direktor | 17. Juni 2026 M | 43.254 | 0 | 5 | $-858.916 |
| Rachelle Suzanne Jacques | Direktor | 10. Juni 2026 A | 33.903 | 0 | 1 | $-53.931 |
| Jeremy P. Springhorn | Direktor | 10. Juni 2026 A | 43.251 | 0 | 1 | $-53.931 |
| Robert Gut | Direktor | 10. Juni 2026 A | 32.259 | 0 | 9 | $-1.757.850 |
| David D. Meek | Direktor | 10. Juni 2026 A | 39.747 | 0 | 1 | $-53.931 |
| Leonard E Post | Direktor | 10. Juni 2026 A | 35.494 | 0 | 1 | $-53.931 |
| Paula Soteropoulos | Direktor | 13. Juni 2024 S | 20.203 | 0 | 0 | $0 |
| Philip Astley-Sparke | Direktor | 2. März 2021 S | 9.946 | 0 | 0 | $0 |
| David Schaffer | Direktor | 27. Februar 2020 A | 46.978 | 0 | 0 | $0 |
| William Lewis | Direktor | 27. Januar 2017 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 12 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,06% | 131.294 SH | 2. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,72% | 81.217 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,34% | 58.938 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,21% | 492.076 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 4.906 SH | 2. Oktober 2026 | Täglich |
| ESML · iShares Trust | 0,05% | 30.024 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 757.841 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 141.093 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 2.657 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 89.136 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 2.897 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 14.325 SH | 11. September 2026 | Täglich |
QURE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 20 Analysten
KAUF
Median-Ziel
$69.54
+196,4%
7 35,0%
Starker Kauf
11 55,0%
Kauf
2 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-10-03Mittelwert-Ziel $65.48 +179,1%
← Unter allen Zielen
Aktueller Preis $23.46
Tief$30.80
Mittelwert$65.48
Hoch$91.95
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 29, 2026